Impact of appointment-based medication synchronization on existing users of chronic medications

Journal of Managed Care Pharmacy

Volumn 21, Issue 8, 2015, Pages 662-669

  Holdford, David ^a   Saxena, Kunal ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIHYDROPYRIDINE CALCIUM CHANNEL BLOCKER; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; METFORMIN; THIAZIDE DIURETIC AGENT; UNCLASSIFIED DRUG;

ADULT; AGED; APPOINTMENT BASED MEDICATION SYNCHRONIZATION; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; HEALTH PROGRAM; HUMAN; INSURANCE; MAJOR CLINICAL STUDY; MALE; MEDICATION COMPLIANCE; MIDDLE AGED; PATIENT CARE; PHARMACY; PRESCRIPTION; RETROSPECTIVE STUDY; CHRONIC DISEASE; COOPERATION; HOSPITAL MANAGEMENT; INTEGRATED HEALTH CARE SYSTEM; INTERDISCIPLINARY COMMUNICATION; PROGRAM EVALUATION; TIME FACTOR; VERY ELDERLY; CLINICAL TRIAL; GENDER; HAZARD RATIO; INFORMATION PROCESSING;

AGED; AGED, 80 AND OVER; APPOINTMENTS AND SCHEDULES; CHRONIC DISEASE; COMMUNITY PHARMACY SERVICES; COOPERATIVE BEHAVIOR; DELIVERY OF HEALTH CARE, INTEGRATED; DRUG PRESCRIPTIONS; FEMALE; HUMANS; INTERDISCIPLINARY COMMUNICATION; MALE; MEDICATION ADHERENCE; MIDDLE AGED; PATIENT CARE TEAM; PROGRAM EVALUATION; RETROSPECTIVE STUDIES; TIME FACTORS;

EID: 84938915917     PISSN: 10834087     EISSN: None     Source Type: Journal    
DOI: 10.18553/jmcp.2015.21.8.662     Document Type: Article

References (22)

1. Sabate E, ed. Adherence to long-term therapy: evidence for action. World Health Organization. 2003. Available at: http://whqlibdoc.who.int/publications/2003/9241545992.pdf. Accessed June 24, 2015.
2. Wong MC, Tam WW, Cheung CS, et al. Drug adherence and the incidence of coronary heart disease-and stroke-specific mortality among 218,047 patients newly prescribed an antihypertensive medication: a fiveyear cohort study. Int J Cardiol. 2013;168(2):928-33.
3. Rasmussen JN, Chong A, Alter DA. Relationship between adherence to evidence-based pharmacotherapy and long-term mortality after acute myocardial infarction. JAMA. 2007;297(2):177-86.
4. Sokol MC, McGuigan KA, Verbrugge RR, Epstein RS. Impact of medication adherence on hospitalization risk and healthcare cost. Med Care. 2005;43(6):521-30.
5. Osterberg L, Blaschke T. Adherence to medication. N Engl J Med. 2005;353(5):487-97.
6. Cutler DM, Everett W. Thinking outside the pillbox-medication adherence as a priority for health care reform. N Engl J Med. 2010;362(17):1553-55.
7. Dimatteo MR. Variations in patients' adherence to medical recommendations:a quantitative review of 50 years of research. Med Care. 2004;42(3):200-09.
8. Benner JS, Glynn RJ, Mogun H, Neumann PJ, Weinstein MC, Avorn J. Long-term persistence in use of statin therapy in elderly patients. JAMA. 2002;288(4):455-61.
9. Cramer JA, Benedict A, Muszbek N, Keskinaslan A, Khan ZM. The significance of compliance and persistence in the treatment of diabetes, hypertension and dyslipidaemia: a review. Int J Clin Pract. 2008;62(1):76-87.
10. Avorn J, Monette J, Lacour A, et al. Persistence of use of lipid-lowering medications: a cross-national study. JAMA. 1998;279(18):1458-62.
11. Briesacher BA, Andrade SE, Fouayzi H, Chan KA. Comparison of drug adherence rates among patients with seven different medical conditions. Pharmacotherapy. 2008;28(4):437-43.
12. Haynes RB, Ackloo E, Sahota N, McDonald HP, Yao X. Interventions for enhancing medication adherence. Cochrane Database Syst Rev. 2008;(2):CD000011.
13. Viswanathan M, Golin CE, Jones CD, et al. Interventions to improve adherence to self-administered medications for chronic diseases in the United States: a systematic review. Ann Intern Med. 2012;157(11):785-95.
14. American Pharmacists Association Foundation. Pharmacy's appointment based model: a prescription synchronization program that improves adherence. APhA Foundation White Paper. August 30, 2013. Available at: http://www.aphafoundation.org/sites/default/files/ckeditor/files/ABMWhitePaper-FINAL-20130923(3).pdf. Accessed June 24, 2015.
15. Holdford DA, Inocencio TJ. Adherence and persistence associated with an appointment-based medication synchronization program. J Am Pharm Assoc (2003). 2013;53(6):576-83.
16. Pharmacy Quality Alliance. PQA performance measures. Updated May 2015. Available at: http://pqaalliance.org/measures/default.asp. Accessed June 24, 2015.
17. Iyengar R, Henderson R, Visaria J, Glave FS. Dispensing channel and medication adherence: evidence across 3 therapy classes. Am J Manag Care. 2013;19(10):798-804.
18. Iyengar RN, Balagere DS, Henderson RR, LeFrancois AL, Rabbitt RM, Frazee SG. Association between dispensing channel and medication adherence among medicare beneficiaries taking medications to treat diabetes, high blood pressure, or high blood cholesterol. J Manag Care Spec Pharm. 2014;20(8):851-61. Available at: http://www.amcp.org/JMCP/2014/August/18390/1033.html.
19. Patrick AR, Shrank WH, Glynn RJ, et al. The association between statin use and outcomes potentially attributable to an unhealthy lifestyle in older adults. Value Health. 2011;14(4):513-20.
20. Putnam DE, Finney JW, Barkley PL, Bonner MJ. Enhancing commitment improves adherence to a medical regimen. J Consult Clin Psychol. 1994;62(1):191-94.
21. Haskard Zolnierek KB, DiMatteo MR. Physician communication and patient adherence to treatment: a meta-analysis. Med Care. 2009;47(8):826-34.
22. Brunton SA. Improving medication adherence in chronic disease management. J Fam Pract. 2011;60(4 Suppl Improving):S1-S8.